Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0NS6I
|
|||
Drug Name |
PMID28766366-Compound-Scheme27LeucettamineB
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
GAMBRO LUNDIA AB [SEJOENSSON LENNART [SENILSSON EDDIE [SESTERNBY JAN [SE]
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H11N3O3
|
|||
Canonical SMILES |
CN1C(=O)C(=CC2=CC3=C(C=C2)OCO3)N=C1N
|
|||
InChI |
1S/C12H11N3O3/c1-15-11(16)8(14-12(15)13)4-7-2-3-9-10(5-7)18-6-17-9/h2-5H,6H2,1H3,(H2,13,14)/b8-4-
|
|||
InChIKey |
PKEDBIGNILOTHW-YWEYNIOJSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.